Laurus Labs
- All
- News
-
Fire At Pharma Lab In Andhra Pradesh Kills 4
- Tuesday December 27, 2022
- India News | Reuters
Indian drugmaker Laurus Labs said on Tuesday that four of its employees died following a flash fire in a room in a manufacturing block of its plant in Visakhapatnam, Andhra Pradesh.
-
www.ndtv.com
-
4 Killed, 1 Injured In Fire At Pharma Company Lab In Andhra Pradesh
- Tuesday December 27, 2022
- India News | Asian News International
Four workers were killed while one was seriously injured in a flash fire that was reported in Paravada Laurus Pharma labs Limited Company in Andhra Pradesh's Anakapalli, according to an official on late Monday evening.
-
www.ndtv.com
-
This Company Is Ready To Flood The US With Cheap HIV Drugs
- Tuesday December 5, 2017
- India News | Ari Altstedter, Bloomberg
Among the coconut plantations and beaches of South India, a factory the size of 35 football fields is preparing to churn out billions of generic pills for HIV patients and flood the US market with the low-cost copycat medicines.
-
www.ndtv.com
-
Fire At Pharma Lab In Andhra Pradesh Kills 4
- Tuesday December 27, 2022
- India News | Reuters
Indian drugmaker Laurus Labs said on Tuesday that four of its employees died following a flash fire in a room in a manufacturing block of its plant in Visakhapatnam, Andhra Pradesh.
-
www.ndtv.com
-
4 Killed, 1 Injured In Fire At Pharma Company Lab In Andhra Pradesh
- Tuesday December 27, 2022
- India News | Asian News International
Four workers were killed while one was seriously injured in a flash fire that was reported in Paravada Laurus Pharma labs Limited Company in Andhra Pradesh's Anakapalli, according to an official on late Monday evening.
-
www.ndtv.com
-
This Company Is Ready To Flood The US With Cheap HIV Drugs
- Tuesday December 5, 2017
- India News | Ari Altstedter, Bloomberg
Among the coconut plantations and beaches of South India, a factory the size of 35 football fields is preparing to churn out billions of generic pills for HIV patients and flood the US market with the low-cost copycat medicines.
-
www.ndtv.com